Clinical trials in mitochondrial disorders, an update.

Area of Science:

• Biochemistry
• Genetics
• Clinical Medicine

Background:

• Mitochondrial disorders are a diverse group of diseases stemming from mitochondrial dysfunction.
• These conditions impact multiple organs and have complex molecular underpinnings.
• Advances in molecular technologies have significantly improved the understanding of disease mechanisms.

Purpose of the Study:

• To review current treatment modalities for mitochondrial disorders.
• To highlight recent and ongoing clinical trials for novel therapies.
• To address the gap between understanding disease mechanisms and therapeutic options.

Main Methods:

• Literature review of current treatments.
• Analysis of recent and ongoing clinical trials.
• Synthesis of information on therapeutic approaches.

Main Results:

• Current treatments are largely symptom-specific and supportive.
• A growing number of clinical trials are exploring targeted therapies.
• Significant progress in understanding disease mechanisms has not yet translated to broad therapeutic advances.

Conclusions:

• Therapeutic options for mitochondrial disorders are limited.
• Clinical trials are crucial for developing more effective treatments.
• Further research is needed to bridge the gap between mechanistic understanding and clinical application.